world cancer report - iarc
world cancer report - iarc
world cancer report - iarc
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
T<br />
Fig. 5.101 Nuclear magnetic resonance imaging<br />
scan of the brain of an HIV-infected patient showing<br />
a large lymphoma (T) in the basal ganglia.<br />
Fig. 5.102 Follicular non-Hodgkin lymphoma.<br />
Detection<br />
The most common presentation of non-<br />
Hodgkin lymphoma is painless swelling of<br />
the lymph nodes in the neck, armpit or<br />
groin. This may be associated with so<br />
called “B symptoms” of unexplained fever,<br />
night sweats and weight loss. Other related<br />
symptoms include fatigue, malaise,<br />
pruritus, or those related to organ involvement<br />
(e.g. indigestion caused by gastric<br />
lymphoma). Extranodal involvement is<br />
common. Diagnosis is dependent on<br />
obtaining a tissue biopsy, usually by excision<br />
of an enlarged node. Pathological<br />
review is crucial to identify the type of<br />
lymphoma.<br />
Staging practice commonly involves full<br />
blood count, biochemical screen including<br />
tests of liver function and renal function,<br />
chest X-ray, CT scan of neck, chest,<br />
abdomen and pelvis, and bone marrow<br />
biopsy. In some instances, lumbar puncture<br />
may be required to assess central<br />
nervous system involvement, which can<br />
have important therapeutic implications.<br />
Hodgkin disease usually originates in<br />
lymph nodes (often in the neck), and only<br />
rarely spreads outside primary lymphoid<br />
tissues. Diagnosis requires a tissue biopsy,<br />
ideally a whole lymph node. Many of<br />
the staging techniques employed are the<br />
same as for non-Hodgkin lymphoma, and<br />
the Ann Arbor staging system is used to<br />
provide treatment planning information<br />
and aid response assessment.<br />
Pathology and genetics<br />
Lymphomas constitute a diverse range of<br />
diseases (Table 5.10). Advances in molecular<br />
biology, genetics and immunology<br />
have meant that there have been profound<br />
changes in the classification of<br />
neoplasms of lymphoid cells over the last<br />
20 years. In the Revised European-<br />
American Lymphoma classification system,<br />
three broad categories are recognized:<br />
Hodgkin disease and T-cell and Bcell<br />
non-Hodgkin lymphomas. A WHO<br />
classification has recently been published<br />
[3]; prior to this the International Working<br />
Formulation (IWF) was the most widely<br />
used classification.<br />
Non-Hodgkin lymphomas are derived<br />
from B or T lymphocytes. In Western<br />
countries, B-cell tumours are more common<br />
(about 75% of cases), whereas T-cell<br />
tumours are less common but are generally<br />
more biologically aggressive. T-cell<br />
tumours are relatively more common in<br />
Table 5.10 Frequency of various types of non-Hodgkin lymphoma.<br />
East Asia. A follicular lymphoma is<br />
defined by the retention of the follicles<br />
within a lymph node (Fig. 5.102), whereas<br />
a diffuse lymphoma results from the infiltration<br />
of the node with effacement of the<br />
follicles by the malignant cells. The size of<br />
the malignant lymphocytes is also important.<br />
In contrast, Hodgkin disease is characterized<br />
by the presence of multinucleate,<br />
giant so-called “Reed-Sternberg” cells,<br />
which may be rare in a particular biopsy<br />
specimen and the surrounding cell proliferation.<br />
The Revised European-American<br />
Lymphoma classification [4] also covers<br />
Hodgkin disease; four histological subtypes<br />
of Hodgkin disease are recognized:<br />
nodular sclerosing, mixed cellularity, lymphocyte<br />
predominance and lymphocyte<br />
depletion.<br />
Many cytogenetic and molecular abnormalities<br />
in non-Hodgkin lymphoma, in<br />
particular Burkitt lymphoma, are caused<br />
by a translocation of the oncogene C-<br />
MYC from chromosome 8 to either the<br />
immunoglobulin heavy chain region on<br />
chromosome 14 or to one of the light<br />
chain loci on chromosomes 2 or 22 [5].<br />
Technological innovations, such as<br />
microarrays, are revolutionizing diagnosis<br />
(Fig. 5.105).<br />
Genetic abnormalities in Hodgkin disease<br />
are less frequently described, perhaps<br />
due to the paucity of malignant cells in<br />
the biopsy specimen.<br />
Diagnosis % of total cases<br />
Diffuse large B-cell lymphoma 30.6<br />
Follicular lymphoma 22.1<br />
MALT lymphoma 7.6<br />
Mature T-cell lymphomas (except ALCL) 7.6<br />
Chronic lymphocytic leukaemia/small lymphocytic 6.7<br />
lymphoma<br />
Mantle cell lymphoma 6.0<br />
Mediastinal large B-cell lymphoma 2.4<br />
Anaplastic large cell lymphoma (ALCL) 2.4<br />
Burkitt lymphoma 2.5<br />
Nodal marginal zone lymphoma 1.8<br />
Precursor T lymphoblastic 1.7<br />
Lymphoplasmacytic lymphoma 1.2<br />
Other types 7.4<br />
Lymphoma<br />
239